Long-term findings of HIVNET 012: the next steps

被引:8
作者
Beckerman, KP [1 ]
机构
[1] NYU, Bellevue Hosp Ctr, Sch Med, New York, NY 10016 USA
关键词
D O I
10.1016/S0140-6736(03)14345-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:842 / 843
页数:2
相关论文
共 16 条
[1]   Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure [J].
Antinori, A ;
Zaccarelli, M ;
Cingolani, A ;
Forbici, F ;
Rizzo, MG ;
Trotta, MP ;
Di Giambenedetto, S ;
Narciso, P ;
Ammassari, A ;
Girardi, E ;
De Luca, A ;
Perno, CF .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (12) :835-838
[2]  
BECKER E, 2003, NY TIMES 0831
[3]   Rates and risk factors for mortality during the first two years of life in rural Malawi [J].
Bloland, P ;
Slutsker, L ;
Steketee, RW ;
Wirima, JJ ;
Heymann, DL ;
Breman, JG .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (01) :82-86
[4]  
*CDCP, 2003, PUBL HLTH SERV TASK
[5]  
*COL U MAILM SCH P, MTCT PLUS EXPANDING
[6]   Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) [J].
Eshleman, SH ;
Mracna, M ;
Guay, LA ;
Deseyve, M ;
Cunningham, S ;
Mirochnick, M ;
Musoke, P ;
Fleming, T ;
Fowler, MG ;
Mofenson, LM ;
Mmiro, F ;
Jackson, JB .
AIDS, 2001, 15 (15) :1951-1957
[7]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[8]   Nevirapine-resistant human immunodeficiency virus: Kinetics of replication and estimated prevalence in untreated patients [J].
Havlir, DV ;
Eastman, S ;
Gamst, A ;
Richman, DD .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7894-7899
[9]   HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/mL receiving combination therapy [J].
Hermankova, M ;
Ray, SC ;
Ruff, C ;
Powell-Davis, M ;
Ingersoll, R ;
D'Aquila, RT ;
Quinn, TC ;
Siliciano, RF ;
Persaud, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :196-207
[10]  
KANTOR R, 2003, 2 IAS C HIV PATH TRE